{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T21:29:14Z","timestamp":1768771754650,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejpb.2024.114181","type":"journal-article","created":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T02:05:28Z","timestamp":1705197928000},"page":"114181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeted intradermal delivery of alpha-arbutin-loaded dissolving polymeric microneedles visualized by three-dimensional Orbitrap secondary ion mass spectrometry (3D OrbiSIMS)"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0734-5473","authenticated-orcid":false,"given":"Zhiwei","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0333-5290","authenticated-orcid":false,"given":"Maria","family":"Marlow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0859-3886","authenticated-orcid":false,"given":"David","family":"Scurr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-3812","authenticated-orcid":false,"given":"Zheying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114181_b0005","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1751-1097.2007.00226.x","article-title":"The protective role of melanin against UV Damage in human skin\u2020","volume":"84","author":"Brenner","year":"2008","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.ejpb.2024.114181_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clindermatol.2013.05.026","article-title":"Pigmentation disorders: hyperpigmentation and hypopigmentation","volume":"32","author":"Nicolaidou","year":"2014","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114181_b0015","unstructured":"Quality of life in dermatology - Halioua - 2000 - International Journal of Dermatology - Wiley Online Library, (n.d.). https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1046\/j.1365-4362.2000.00793.x?casa_token=-PoIQ2zd-38AAAAA%3ADMJHqNN6uvOEut6_yqQeuwJw9oveonoi0_5L6AI_fcgRZIAJWqm6WcIsgWlgGm0dEOk4K3x9RZ4qOA (accessed October 30, 2022)."},{"key":"10.1016\/j.ejpb.2024.114181_b0020","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1055\/a-0583-0410","article-title":"Plants and Natural Products for the Treatment of Skin Hyperpigmentation \u2013 A Review","volume":"84","author":"Kanlayavattanakul","year":"2018","journal-title":"Planta Med."},{"key":"10.1016\/j.ejpb.2024.114181_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1034\/j.1600-0749.2003.00029.x","article-title":"Chemical and Instrumental Approaches to Treat Hyperpigmentation","volume":"16","author":"Briganti","year":"2003","journal-title":"Pigment Cell Res."},{"key":"10.1016\/j.ejpb.2024.114181_b0030","first-page":"797","article-title":"Pigmentation Disorders: Diagnosis and Management","volume":"96","author":"Plensdorf","year":"2017","journal-title":"Am Fam Physician."},{"key":"10.1016\/j.ejpb.2024.114181_b0035","doi-asserted-by":"crossref","first-page":"7395","DOI":"10.1021\/acs.jmedchem.7b00967","article-title":"Inhibitors of Melanogenesis: An Updated Review","volume":"61","author":"Pillaiyar","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2024.114181_b0040","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1248\/cpb.51.798","article-title":"Syntheses of Arbutin-\u03b1-glycosides and a Comparison of Their Inhibitory Effects with Those of \u03b1-Arbutin and Arbutin on Human Tyrosinase","volume":"51","author":"Sugimoto","year":"2003","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2024.114181_b0045","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-2133.2003.05163.x","article-title":"The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by microdialysis","volume":"148","author":"Morgan","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114181_b0050","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jdermsci.2009.12.014","article-title":"Bidimensional analysis of desmoglein 1 distribution on the outermost corneocytes provides the structural and functional information of the stratum corneum","volume":"57","author":"Naoe","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejpb.2024.114181_b0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2017.06.002","article-title":"Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis","volume":"88","author":"Akiyama","year":"2017","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejpb.2024.114181_b0060","unstructured":"M.R. Prausnitz, P.M. Elias, T.J. Franz, M. Schmuth, J.-C. Tsai, G.K. Menon, W.M. Holleran, K.R. Feingold, 124 Skin Barrier and Transdermal Drug Delivery, (n.d.) 10."},{"key":"10.1016\/j.ejpb.2024.114181_b0065","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.carres.2011.08.028","article-title":"Development of chitosan\u2013tripolyphosphate fibers through pH dependent ionotropic gelation","volume":"346","author":"Pati","year":"2011","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejpb.2024.114181_b0070","doi-asserted-by":"crossref","unstructured":"N. Chandorkar, S. Tambe, P. Amin, C. Madankar, Alpha Arbutin as a Skin Lightening Agent: A Review, 13 (2021) 3502\u20133510. 10.31838\/ijpr\/2021.13.02.446.","DOI":"10.31838\/ijpr\/2021.13.02.446"},{"key":"10.1016\/j.ejpb.2024.114181_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.2042-7158.2011.01369.x","article-title":"Microneedles: an emerging transdermal drug delivery system","volume":"64","author":"Bariya","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114181_b0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.022","article-title":"Topical and cutaneous delivery using nanosystems","volume":"247","author":"Roberts","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114181_b0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.aca.2019.02.031","article-title":"Recent advances in the fabrication and application of nanomaterial-based enzymatic microsystems in chemical and biological sciences","volume":"1067","author":"Hong","year":"2019","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejpb.2024.114181_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.addr.2003.08.012","article-title":"Integrated microsystems for controlled drug delivery","volume":"56","author":"Razzacki","year":"2004","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114181_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cej.2019.02.168","article-title":"Core-shell materials, lipid particles and nanoemulsions, for delivery of active anti-oxidants in cosmetics applications: Challenges and development strategies","volume":"368","author":"Van Tran","year":"2019","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.ejpb.2024.114181_b0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114181_b0105","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2008.05.002","article-title":"Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy","volume":"129","author":"Donnelly","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114181_b0110","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.ejpb.2008.02.009","article-title":"Influence of the delivery systems using a microneedle array on the permeation of a hydrophilic molecule, calcein","volume":"69","author":"Oh","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114181_b0115","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2024.114181_b0120","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2013.05.005","article-title":"Microneedles for intradermal and transdermal drug delivery","volume":"50","author":"Tuan-Mahmood","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2024.114181_b0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejpb.2019.02.006","article-title":"Insight into imiquimod skin permeation and increased delivery using microneedle pre-treatment","volume":"139","author":"Al-Mayahy","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114181_b0130","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.biopha.2018.10.078","article-title":"Microneedles: A smart approach and increasing potential for transdermal drug delivery system","volume":"109","author":"Waghule","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2024.114181_b0135","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/lapl.200910134","article-title":"In vivo visualization of microneedle conduits in human skin using laser scanning microscopy","volume":"7","author":"Bal","year":"2010","journal-title":"Laser Phys. Lett."},{"key":"10.1016\/j.ejpb.2024.114181_b0140","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1021\/acs.molpharmaceut.0c00347","article-title":"Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules","volume":"17","author":"Sabri","year":"2020","journal-title":"Mol. Pharmaceutics."},{"key":"10.1016\/j.ejpb.2024.114181_b0145","article-title":"Microneedle System for Transdermal Drug and Vaccine Delivery: Devices","volume":"17","author":"He","year":"2019","journal-title":"Safety, and Prospects, Dose-Response."},{"key":"10.1016\/j.ejpb.2024.114181_b0150","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1080\/09205063.2022.2155778","article-title":"PVP-microneedle array for drug delivery: mechanical insight, biodegradation, and recent advances","volume":"34","author":"Mangang","year":"2023","journal-title":"J. Biomater. Sci., Polymer Edition."},{"key":"10.1016\/j.ejpb.2024.114181_b0155","first-page":"543","article-title":"Transdermal delivery of cosmetic ingredients using dissolving polymer microneedle arrays, Biotechnology and Bioprocess","volume":"20","author":"Park","year":"2015","journal-title":"Engineering"},{"key":"10.1016\/j.ejpb.2024.114181_b0160","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.3390\/polym13162815","article-title":"A Comprehensive Review of Microneedles: Types, Materials, Processes, Characterizations and Applications","volume":"13","author":"Aldawood","year":"2021","journal-title":"Polymers."},{"key":"10.1016\/j.ejpb.2024.114181_b0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1208\/s12249-019-1599-1","article-title":"HPMC\/PVP Dissolving Microneedles: a Promising Delivery Platform to Promote Trans-Epidermal Delivery of Alpha-Arbutin for Skin Lightening","volume":"21","author":"Aung","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2024.114181_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119508","article-title":"Fabrication, characterization and comparison of \u03b1-arbutin loaded dissolving and hydrogel forming microneedles","volume":"586","author":"Aung","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114181_b0175","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1007\/s11095-013-1032-5","article-title":"Distribution and Visualisation of Chlorhexidine Within the Skin Using ToF-SIMS: A Potential Platform for the Design of More Efficacious Skin Antiseptic Formulations","volume":"30","author":"Judd","year":"2013","journal-title":"Pharm Res."},{"key":"10.1016\/j.ejpb.2024.114181_b0180","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1016\/j.apsusc.2006.02.218","article-title":"TOF-SIMS investigation of the distribution of a cosmetic ingredient in the epidermis of the skin","volume":"252","author":"Okamoto","year":"2006","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.ejpb.2024.114181_b0185","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1039\/D2AN00913G","article-title":"Characterisation of Sr 2+ mobility in osteoporotic rat bone marrow by cryo-ToF-SIMS and cryo-OrbiSIMS","volume":"147","author":"Kern","year":"2022","journal-title":"Analyst"},{"key":"10.1016\/j.ejpb.2024.114181_b0190","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1039\/C9JA00118B","article-title":"SIMS imaging in neurobiology and cell biology","volume":"34","author":"Ag\u00fci-Gonzalez","year":"2019","journal-title":"J. Anal. At. Spectrom"},{"key":"10.1016\/j.ejpb.2024.114181_b0195","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/nmeth.4504","article-title":"The 3D OrbiSIMS\u2014label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power","volume":"14","author":"Passarelli","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejpb.2024.114181_b0200","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1038\/s41467-020-19445-x","article-title":"Protein identification by 3D OrbiSIMS to facilitate in situ imaging and depth profiling","volume":"11","author":"Kotowska","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.ejpb.2024.114181_b0205","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1021\/acs.jmedchem.3c00012","article-title":"Design, Synthesis, and Biological Evaluation of Novel Hybrids Containing Dihydrochalcone as Tyrosinase Inhibitors to Treat Skin Hyperpigmentation","volume":"66","author":"Xue","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejpb.2024.114181_b0210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1523-1747.ep12533356","article-title":"Percutaneous Absorption. On the Relevance of in Vitro Data","volume":"64","author":"Franz","year":"1975","journal-title":"J, Invest. Dermatol."},{"key":"10.1016\/j.ejpb.2024.114181_b0215","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.tiv.2003.10.004","article-title":"Multi-species assessment of electrical resistance as a skin integrity marker for in vitro percutaneous absorption studies","volume":"18","author":"Davies","year":"2004","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.ejpb.2024.114181_b0220","doi-asserted-by":"crossref","unstructured":"G.A. Shabir, Validation of high-performance liquid chromatography methods for pharmaceutical analysis: Understanding the differences and similarities between validation requirements of the US Food and Drug Administration, the US Pharmacopeia and the International Conference on Harmonization, Journal of Chromatography A. 987 (2003) 57\u201366. 10.1016\/S0021-9673(02)01536-4.","DOI":"10.1016\/S0021-9673(02)01536-4"},{"key":"10.1016\/j.ejpb.2024.114181_b0225","unstructured":"C. for D.E. and Research, Analytical Procedures and Methods Validation for Drugs and Biologics, U.S. Food and Drug Administration. (2020). https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/analytical-procedures-and-methods-validation-drugs-and-biologics (accessed October 30, 2022)."},{"key":"10.1016\/j.ejpb.2024.114181_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119808","article-title":"Intradermal delivery of imiquimod using polymeric microneedles for basal cell carcinoma","volume":"589","author":"Sabri","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114181_b0235","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.4314\/tjpr.v13i11.1","article-title":"Improvement of arbutin trans-epidermal delivery using radiofrequency microporation","volume":"13","author":"Won","year":"2014","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.ejpb.2024.114181_b0240","first-page":"113","article-title":"What to use to express the variability of data: Standard deviation or standard error of mean?, Perspect","volume":"3","author":"Barde","year":"2012","journal-title":"Clin Res."},{"key":"10.1016\/j.ejpb.2024.114181_b0245","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2011.05.021","article-title":"Kinetics of skin resealing after insertion of microneedles in human subjects","volume":"154","author":"Gupta","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114181_b0250","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.apsb.2019.03.007","article-title":"Recent advances of microneedles for biomedical applications: drug delivery and beyond","volume":"9","author":"Yang","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2024.114181_b0255","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2114380119","article-title":"Elucidating the molecular landscape of the stratum corneum","volume":"119","author":"Starr","year":"2022","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2024.114181_b0260","article-title":"Polymeric microneedles for transdermal drug delivery-a review of recent studies","volume":"103760","author":"Karim","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.ejpb.2024.114181_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2022.103639","article-title":"Recent advances in microneedle designs and their applications in drug and cosmeceutical delivery","volume":"75","author":"Parhi","year":"2022","journal-title":"J. Drug Delivery Sci. Technol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T19:47:19Z","timestamp":1737834439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":53,"alternative-id":["S0939641124000079"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114181","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted intradermal delivery of alpha-arbutin-loaded dissolving polymeric microneedles visualized by three-dimensional Orbitrap secondary ion mass spectrometry (3D OrbiSIMS)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114181"}}